rs73110310

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003238.6(TGFB2):​c.-714A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 151,162 control chromosomes in the GnomAD database, including 1,569 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.10 ( 1569 hom., cov: 30)

Consequence

TGFB2
NM_003238.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.389

Publications

0 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2-AS1 (HGNC:50628): (TGFB2 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-218345988-A-C is Benign according to our data. Variant chr1-218345988-A-C is described in ClinVar as Benign. ClinVar VariationId is 295463.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.262 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.-714A>C
5_prime_UTR
Exon 1 of 7NP_003229.1P61812-1
TGFB2
NM_001135599.4
c.-714A>C
5_prime_UTR
Exon 1 of 8NP_001129071.1P61812-2
TGFB2
NR_138148.2
n.653A>C
non_coding_transcript_exon
Exon 1 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.-714A>C
5_prime_UTR
Exon 1 of 7ENSP00000355897.4P61812-1
TGFB2-AS1
ENST00000414452.3
TSL:3
n.63T>G
non_coding_transcript_exon
Exon 1 of 3
TGFB2-AS1
ENST00000689961.3
n.55T>G
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.101
AC:
15234
AN:
151044
Hom.:
1556
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.266
Gnomad AMI
AF:
0.0299
Gnomad AMR
AF:
0.0537
Gnomad ASJ
AF:
0.0424
Gnomad EAS
AF:
0.0803
Gnomad SAS
AF:
0.0115
Gnomad FIN
AF:
0.0219
Gnomad MID
AF:
0.0449
Gnomad NFE
AF:
0.0370
Gnomad OTH
AF:
0.0779
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.101
AC:
15284
AN:
151162
Hom.:
1569
Cov.:
30
AF XY:
0.0981
AC XY:
7242
AN XY:
73856
show subpopulations
African (AFR)
AF:
0.266
AC:
10923
AN:
41020
American (AMR)
AF:
0.0535
AC:
816
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0424
AC:
147
AN:
3470
East Asian (EAS)
AF:
0.0803
AC:
402
AN:
5008
South Asian (SAS)
AF:
0.0117
AC:
56
AN:
4794
European-Finnish (FIN)
AF:
0.0219
AC:
231
AN:
10554
Middle Eastern (MID)
AF:
0.0517
AC:
15
AN:
290
European-Non Finnish (NFE)
AF:
0.0370
AC:
2505
AN:
67762
Other (OTH)
AF:
0.0771
AC:
162
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
533
1067
1600
2134
2667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0458
Hom.:
375
Bravo
AF:
0.113
Asia WGS
AF:
0.0440
AC:
152
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Loeys-Dietz syndrome 4 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.3
DANN
Benign
0.56
PhyloP100
-0.39
PromoterAI
0.025
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73110310; hg19: chr1-218519330; API